Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study

2020-05-18

Blood Cancer Journal , Volume 10 - Issue 5

Additional Metadata
Persistent URL	doi.org/10.1038/s41408-020-0326-1, hdl.handle.net/1765/127223
Journal	Blood Cancer Journal
Organisation	Department of Hematology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Mina, R., Belotti, A. (Angelo), Petrucci, M., Zambello, R., Capra, A. (Andrea), Di Lullo, G. (Giacomo), … Larocca, A. (2020). Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study. Blood Cancer Journal, 10(5). doi:10.1038/s41408-020-0326-1

Publication